ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neuroscience Antibody Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-39P13391
Home | Market Reports | Science| Biological Sciences
Global Neuroscience Antibody Market Research Report 2023
BUY CHAPTERS

Global Neuroscience Antibody Market Research Report 2025

Code: QYRE-Auto-39P13391
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abcam
BioLegend
Bio-Rad Laboratories Inc
Cell Signaling Technology
Roche
Genscript Biotech Corp
Merck KGaA
Rockland Immunochemicals Inc.
Santa Cruz Biotechnology; Inc
Siemens Healthineers
Tecan Group Ltd
Thermo Fisher Scientific Inc
Enzo Life Sciences AG
Neobioscience

Neuroscience Antibody Market Size

The global market for Neuroscience Antibody was valued at US$ 3860 million in the year 2024 and is projected to reach a revised size of US$ 6442 million by 2031, growing at a CAGR of 7.7% during the forecast period.

Neuroscience Antibody Market

Neuroscience Antibody Market

Neuroscience Antibodies are major tools to clarify the process and mechanism which take place during neural development and related disease. The key to neuroscience research is the identification of cellular, molecular and tissue features that can be used as biomarkers to help identify patients at risk for neurological disease and as targets for new therapies.
The global neuroscience antibody market refers to the market for antibodies used in neuroscience research and diagnostics. Antibodies are essential tools for studying the structure, function, and interactions of proteins in the brain and nervous system.
Neuroscience research plays a critical role in understanding the complexities of the brain and nervous system, as well as in developing effective treatments for neurological disorders and diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and depression. Antibodies are widely used in techniques such as immunohistochemistry, immunocytochemistry, Western blotting, and enzyme-linked immunosorbent assay (ELISA) for the detection and analysis of specific protein targets.
The market for neuroscience antibodies is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the growing elderly population worldwide are fueling the demand for research and diagnostic tools. Neuroscience antibodies play a fundamental role in identifying biomarkers, studying disease mechanisms, and developing targeted therapies.
Secondly, technological advancements in antibody development and conjugation techniques have expanded the range of applications and improved the specificity and sensitivity of neuroscience antibodies. This has led to increased adoption and demand for these antibodies in both academic and pharmaceutical research settings.
Thirdly, government and private funding initiatives aimed at promoting neuroscience research and drug discovery programs have further contributed to the growth of the neuroscience antibody market. Increased funding allows for more extensive research projects and the development of new antibodies targeting specific protein markers associated with neurological disorders.
The market for neuroscience antibodies is segmented based on the type of antibody, including monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies are highly specific and are commonly used for targeted detection and analysis of protein markers. Polyclonal antibodies, on the other hand, exhibit a broader range of binding affinities and are often used for screening and initial characterization purposes.
Geographically, the market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has been a significant market for neuroscience antibodies due to the presence of well-established research institutions, pharmaceutical companies, and government support for neuroscience research. The Asia Pacific region is expected to witness significant market growth due to the increasing focus on neuroscience research and rising healthcare investments.
Key players in the global neuroscience antibody market include manufacturers specializing in antibody production, as well as biotechnology and pharmaceutical companies involved in neuroscience research and drug discovery. These companies offer a wide range of neuroscience antibodies targeting various protein markers and provide customization services to meet specific research needs. Collaboration with researchers and academia, as well as strategic mergers and acquisitions, are common strategies employed by key players to expand their market presence.
In summary, the global neuroscience antibody market is driven by factors such as the increasing prevalence of neurological disorders, technological advancements in antibody development, and research funding initiatives. Monoclonal and polyclonal antibodies are the two major types of antibodies used in neuroscience research. With ongoing advancements and the increasing focus on understanding the complexities of the brain, the neuroscience antibody market is expected to grow, providing valuable tools for researchers and contributing to advancements in neurological disease treatment and diagnostics.The global neuroscience antibody market refers to the market for antibodies used in neuroscience research and diagnostics. Antibodies are essential tools for studying the structure, function, and interactions of proteins in the brain and nervous system.
Neuroscience research plays a critical role in understanding the complexities of the brain and nervous system, as well as in developing effective treatments for neurological disorders and diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and depression. Antibodies are widely used in techniques such as immunohistochemistry, immunocytochemistry, Western blotting, and enzyme-linked immunosorbent assay (ELISA) for the detection and analysis of specific protein targets.
The market for neuroscience antibodies is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the growing elderly population worldwide are fueling the demand for research and diagnostic tools. Neuroscience antibodies play a fundamental role in identifying biomarkers, studying disease mechanisms, and developing targeted therapies.
Secondly, technological advancements in antibody development and conjugation techniques have expanded the range of applications and improved the specificity and sensitivity of neuroscience antibodies. This has led to increased adoption and demand for these antibodies in both academic and pharmaceutical research settings.
Thirdly, government and private funding initiatives aimed at promoting neuroscience research and drug discovery programs have further contributed to the growth of the neuroscience antibody market. Increased funding allows for more extensive research projects and the development of new antibodies targeting specific protein markers associated with neurological disorders.
The market for neuroscience antibodies is segmented based on the type of antibody, including monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies are highly specific and are commonly used for targeted detection and analysis of protein markers. Polyclonal antibodies, on the other hand, exhibit a broader range of binding affinities and are often used for screening and initial characterization purposes.
Geographically, the market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has been a significant market for neuroscience antibodies due to the presence of well-established research institutions, pharmaceutical companies, and government support for neuroscience research. The Asia Pacific region is expected to witness significant market growth due to the increasing focus on neuroscience research and rising healthcare investments.
Key players in the global neuroscience antibody market include manufacturers specializing in antibody production, as well as biotechnology and pharmaceutical companies involved in neuroscience research and drug discovery. These companies offer a wide range of neuroscience antibodies targeting various protein markers and provide customization services to meet specific research needs. Collaboration with researchers and academia, as well as strategic mergers and acquisitions, are common strategies employed by key players to expand their market presence.
In summary, the global neuroscience antibody market is driven by factors such as the increasing prevalence of neurological disorders, technological advancements in antibody development, and research funding initiatives. Monoclonal and polyclonal antibodies are the two major types of antibodies used in neuroscience research. With ongoing advancements and the increasing focus on understanding the complexities of the brain, the neuroscience antibody market is expected to grow, providing valuable tools for researchers and contributing to advancements in neurological disease treatment and diagnostics.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibody.
The Neuroscience Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuroscience Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroscience Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Neuroscience Antibody Market Report

Report Metric Details
Report Name Neuroscience Antibody Market
Accounted market size in year US$ 3860 million
Forecasted market size in 2031 US$ 6442 million
CAGR 7.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals and Diagnostics Centers
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abcam, BioLegend, Bio-Rad Laboratories Inc, Cell Signaling Technology, Roche, Genscript Biotech Corp, Merck KGaA, Rockland Immunochemicals Inc, Santa Cruz Biotechnology Inc, Siemens Healthineers, Tecan Group Ltd, Thermo Fisher Scientific Inc, Enzo Life Sciences AG, Neobioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Neuroscience Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Neuroscience Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Neuroscience Antibody Market growing?

Ans: The Neuroscience Antibody Market witnessing a CAGR of 7.7% during the forecast period 2025-2031.

What is the Neuroscience Antibody Market size in 2031?

Ans: The Neuroscience Antibody Market size in 2031 will be US$ 6442 million.

Who are the main players in the Neuroscience Antibody Market report?

Ans: The main players in the Neuroscience Antibody Market are Abcam, BioLegend, Bio-Rad Laboratories Inc, Cell Signaling Technology, Roche, Genscript Biotech Corp, Merck KGaA, Rockland Immunochemicals Inc, Santa Cruz Biotechnology Inc, Siemens Healthineers, Tecan Group Ltd, Thermo Fisher Scientific Inc, Enzo Life Sciences AG, Neobioscience

What are the Application segmentation covered in the Neuroscience Antibody Market report?

Ans: The Applications covered in the Neuroscience Antibody Market report are Hospitals and Diagnostics Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies

What are the Type segmentation covered in the Neuroscience Antibody Market report?

Ans: The Types covered in the Neuroscience Antibody Market report are Antibodies, Research Reagents

Recommended Reports

Neuroscience Diagnostics

Alzheimer's Markets

Antibody Technologies

1 Neuroscience Antibody Market Overview
1.1 Product Definition
1.2 Neuroscience Antibody by Type
1.2.1 Global Neuroscience Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 Antibodies
1.2.3 Research Reagents
1.3 Neuroscience Antibody by Application
1.3.1 Global Neuroscience Antibody Market Value by Application (2024 VS 2031)
1.3.2 Hospitals and Diagnostics Centers
1.3.3 Academic and Research Institutes
1.3.4 Pharmaceutical and Biotechnology Companies
1.4 Global Neuroscience Antibody Market Size Estimates and Forecasts
1.4.1 Global Neuroscience Antibody Revenue 2020-2031
1.4.2 Global Neuroscience Antibody Sales 2020-2031
1.4.3 Global Neuroscience Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Neuroscience Antibody Market Competition by Manufacturers
2.1 Global Neuroscience Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Neuroscience Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Neuroscience Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Neuroscience Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neuroscience Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neuroscience Antibody, Product Type & Application
2.7 Global Key Manufacturers of Neuroscience Antibody, Date of Enter into This Industry
2.8 Global Neuroscience Antibody Market Competitive Situation and Trends
2.8.1 Global Neuroscience Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Neuroscience Antibody Players Market Share by Revenue
2.8.3 Global Neuroscience Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neuroscience Antibody Market Scenario by Region
3.1 Global Neuroscience Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Neuroscience Antibody Sales by Region: 2020-2031
3.2.1 Global Neuroscience Antibody Sales by Region: 2020-2025
3.2.2 Global Neuroscience Antibody Sales by Region: 2026-2031
3.3 Global Neuroscience Antibody Revenue by Region: 2020-2031
3.3.1 Global Neuroscience Antibody Revenue by Region: 2020-2025
3.3.2 Global Neuroscience Antibody Revenue by Region: 2026-2031
3.4 North America Neuroscience Antibody Market Facts & Figures by Country
3.4.1 North America Neuroscience Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Neuroscience Antibody Sales by Country (2020-2031)
3.4.3 North America Neuroscience Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neuroscience Antibody Market Facts & Figures by Country
3.5.1 Europe Neuroscience Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Neuroscience Antibody Sales by Country (2020-2031)
3.5.3 Europe Neuroscience Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neuroscience Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Neuroscience Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Neuroscience Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Neuroscience Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neuroscience Antibody Market Facts & Figures by Country
3.7.1 Latin America Neuroscience Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Neuroscience Antibody Sales by Country (2020-2031)
3.7.3 Latin America Neuroscience Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neuroscience Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Neuroscience Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Neuroscience Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Neuroscience Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neuroscience Antibody Sales by Type (2020-2031)
4.1.1 Global Neuroscience Antibody Sales by Type (2020-2025)
4.1.2 Global Neuroscience Antibody Sales by Type (2026-2031)
4.1.3 Global Neuroscience Antibody Sales Market Share by Type (2020-2031)
4.2 Global Neuroscience Antibody Revenue by Type (2020-2031)
4.2.1 Global Neuroscience Antibody Revenue by Type (2020-2025)
4.2.2 Global Neuroscience Antibody Revenue by Type (2026-2031)
4.2.3 Global Neuroscience Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Neuroscience Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Neuroscience Antibody Sales by Application (2020-2031)
5.1.1 Global Neuroscience Antibody Sales by Application (2020-2025)
5.1.2 Global Neuroscience Antibody Sales by Application (2026-2031)
5.1.3 Global Neuroscience Antibody Sales Market Share by Application (2020-2031)
5.2 Global Neuroscience Antibody Revenue by Application (2020-2031)
5.2.1 Global Neuroscience Antibody Revenue by Application (2020-2025)
5.2.2 Global Neuroscience Antibody Revenue by Application (2026-2031)
5.2.3 Global Neuroscience Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Neuroscience Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abcam
6.1.1 Abcam Company Information
6.1.2 Abcam Description and Business Overview
6.1.3 Abcam Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abcam Neuroscience Antibody Product Portfolio
6.1.5 Abcam Recent Developments/Updates
6.2 BioLegend
6.2.1 BioLegend Company Information
6.2.2 BioLegend Description and Business Overview
6.2.3 BioLegend Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BioLegend Neuroscience Antibody Product Portfolio
6.2.5 BioLegend Recent Developments/Updates
6.3 Bio-Rad Laboratories Inc
6.3.1 Bio-Rad Laboratories Inc Company Information
6.3.2 Bio-Rad Laboratories Inc Description and Business Overview
6.3.3 Bio-Rad Laboratories Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bio-Rad Laboratories Inc Neuroscience Antibody Product Portfolio
6.3.5 Bio-Rad Laboratories Inc Recent Developments/Updates
6.4 Cell Signaling Technology
6.4.1 Cell Signaling Technology Company Information
6.4.2 Cell Signaling Technology Description and Business Overview
6.4.3 Cell Signaling Technology Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cell Signaling Technology Neuroscience Antibody Product Portfolio
6.4.5 Cell Signaling Technology Recent Developments/Updates
6.5 Roche
6.5.1 Roche Company Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Roche Neuroscience Antibody Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Genscript Biotech Corp
6.6.1 Genscript Biotech Corp Company Information
6.6.2 Genscript Biotech Corp Description and Business Overview
6.6.3 Genscript Biotech Corp Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Genscript Biotech Corp Neuroscience Antibody Product Portfolio
6.6.5 Genscript Biotech Corp Recent Developments/Updates
6.7 Merck KGaA
6.7.1 Merck KGaA Company Information
6.7.2 Merck KGaA Description and Business Overview
6.7.3 Merck KGaA Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck KGaA Neuroscience Antibody Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
6.8 Rockland Immunochemicals Inc
6.8.1 Rockland Immunochemicals Inc Company Information
6.8.2 Rockland Immunochemicals Inc Description and Business Overview
6.8.3 Rockland Immunochemicals Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Rockland Immunochemicals Inc Neuroscience Antibody Product Portfolio
6.8.5 Rockland Immunochemicals Inc Recent Developments/Updates
6.9 Santa Cruz Biotechnology Inc
6.9.1 Santa Cruz Biotechnology Inc Company Information
6.9.2 Santa Cruz Biotechnology Inc Description and Business Overview
6.9.3 Santa Cruz Biotechnology Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Santa Cruz Biotechnology Inc Neuroscience Antibody Product Portfolio
6.9.5 Santa Cruz Biotechnology Inc Recent Developments/Updates
6.10 Siemens Healthineers
6.10.1 Siemens Healthineers Company Information
6.10.2 Siemens Healthineers Description and Business Overview
6.10.3 Siemens Healthineers Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Siemens Healthineers Neuroscience Antibody Product Portfolio
6.10.5 Siemens Healthineers Recent Developments/Updates
6.11 Tecan Group Ltd
6.11.1 Tecan Group Ltd Company Information
6.11.2 Tecan Group Ltd Description and Business Overview
6.11.3 Tecan Group Ltd Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Tecan Group Ltd Neuroscience Antibody Product Portfolio
6.11.5 Tecan Group Ltd Recent Developments/Updates
6.12 Thermo Fisher Scientific Inc
6.12.1 Thermo Fisher Scientific Inc Company Information
6.12.2 Thermo Fisher Scientific Inc Description and Business Overview
6.12.3 Thermo Fisher Scientific Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Thermo Fisher Scientific Inc Neuroscience Antibody Product Portfolio
6.12.5 Thermo Fisher Scientific Inc Recent Developments/Updates
6.13 Enzo Life Sciences AG
6.13.1 Enzo Life Sciences AG Company Information
6.13.2 Enzo Life Sciences AG Description and Business Overview
6.13.3 Enzo Life Sciences AG Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Enzo Life Sciences AG Neuroscience Antibody Product Portfolio
6.13.5 Enzo Life Sciences AG Recent Developments/Updates
6.14 Neobioscience
6.14.1 Neobioscience Company Information
6.14.2 Neobioscience Description and Business Overview
6.14.3 Neobioscience Neuroscience Antibody Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Neobioscience Neuroscience Antibody Product Portfolio
6.14.5 Neobioscience Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neuroscience Antibody Industry Chain Analysis
7.2 Neuroscience Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neuroscience Antibody Production Mode & Process Analysis
7.4 Neuroscience Antibody Sales and Marketing
7.4.1 Neuroscience Antibody Sales Channels
7.4.2 Neuroscience Antibody Distributors
7.5 Neuroscience Antibody Customer Analysis
8 Neuroscience Antibody Market Dynamics
8.1 Neuroscience Antibody Industry Trends
8.2 Neuroscience Antibody Market Drivers
8.3 Neuroscience Antibody Market Challenges
8.4 Neuroscience Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abcam
BioLegend
Bio-Rad Laboratories Inc
Cell Signaling Technology
Roche
Genscript Biotech Corp
Merck KGaA
Rockland Immunochemicals Inc.
Santa Cruz Biotechnology; Inc
Siemens Healthineers
Tecan Group Ltd
Thermo Fisher Scientific Inc
Enzo Life Sciences AG
Neobioscience
List of Tables
 Table 1. Global Neuroscience Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Neuroscience Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Neuroscience Antibody Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Neuroscience Antibody Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Neuroscience Antibody Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Neuroscience Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Neuroscience Antibody Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Neuroscience Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Neuroscience Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Neuroscience Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Neuroscience Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of Neuroscience Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Neuroscience Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibody as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Neuroscience Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Neuroscience Antibody Sales by Region (2020-2025) & (K Units)
 Table 18. Global Neuroscience Antibody Sales Market Share by Region (2020-2025)
 Table 19. Global Neuroscience Antibody Sales by Region (2026-2031) & (K Units)
 Table 20. Global Neuroscience Antibody Sales Market Share by Region (2026-2031)
 Table 21. Global Neuroscience Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Neuroscience Antibody Revenue Market Share by Region (2020-2025)
 Table 23. Global Neuroscience Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Neuroscience Antibody Revenue Market Share by Region (2026-2031)
 Table 25. North America Neuroscience Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Neuroscience Antibody Sales by Country (2020-2025) & (K Units)
 Table 27. North America Neuroscience Antibody Sales by Country (2026-2031) & (K Units)
 Table 28. North America Neuroscience Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Neuroscience Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Neuroscience Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Neuroscience Antibody Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Neuroscience Antibody Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Neuroscience Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Neuroscience Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Neuroscience Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Neuroscience Antibody Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Neuroscience Antibody Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Neuroscience Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Neuroscience Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Neuroscience Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Neuroscience Antibody Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Neuroscience Antibody Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Neuroscience Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Neuroscience Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Neuroscience Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Neuroscience Antibody Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Neuroscience Antibody Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Neuroscience Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Neuroscience Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Neuroscience Antibody Sales (K Units) by Type (2020-2025)
 Table 51. Global Neuroscience Antibody Sales (K Units) by Type (2026-2031)
 Table 52. Global Neuroscience Antibody Sales Market Share by Type (2020-2025)
 Table 53. Global Neuroscience Antibody Sales Market Share by Type (2026-2031)
 Table 54. Global Neuroscience Antibody Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Neuroscience Antibody Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Neuroscience Antibody Revenue Market Share by Type (2020-2025)
 Table 57. Global Neuroscience Antibody Revenue Market Share by Type (2026-2031)
 Table 58. Global Neuroscience Antibody Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Neuroscience Antibody Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Neuroscience Antibody Sales (K Units) by Application (2020-2025)
 Table 61. Global Neuroscience Antibody Sales (K Units) by Application (2026-2031)
 Table 62. Global Neuroscience Antibody Sales Market Share by Application (2020-2025)
 Table 63. Global Neuroscience Antibody Sales Market Share by Application (2026-2031)
 Table 64. Global Neuroscience Antibody Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Neuroscience Antibody Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Neuroscience Antibody Revenue Market Share by Application (2020-2025)
 Table 67. Global Neuroscience Antibody Revenue Market Share by Application (2026-2031)
 Table 68. Global Neuroscience Antibody Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Neuroscience Antibody Price (US$/Unit) by Application (2026-2031)
 Table 70. Abcam Company Information
 Table 71. Abcam Description and Business Overview
 Table 72. Abcam Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abcam Neuroscience Antibody Product
 Table 74. Abcam Recent Developments/Updates
 Table 75. BioLegend Company Information
 Table 76. BioLegend Description and Business Overview
 Table 77. BioLegend Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BioLegend Neuroscience Antibody Product
 Table 79. BioLegend Recent Developments/Updates
 Table 80. Bio-Rad Laboratories Inc Company Information
 Table 81. Bio-Rad Laboratories Inc Description and Business Overview
 Table 82. Bio-Rad Laboratories Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bio-Rad Laboratories Inc Neuroscience Antibody Product
 Table 84. Bio-Rad Laboratories Inc Recent Developments/Updates
 Table 85. Cell Signaling Technology Company Information
 Table 86. Cell Signaling Technology Description and Business Overview
 Table 87. Cell Signaling Technology Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Cell Signaling Technology Neuroscience Antibody Product
 Table 89. Cell Signaling Technology Recent Developments/Updates
 Table 90. Roche Company Information
 Table 91. Roche Description and Business Overview
 Table 92. Roche Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Roche Neuroscience Antibody Product
 Table 94. Roche Recent Developments/Updates
 Table 95. Genscript Biotech Corp Company Information
 Table 96. Genscript Biotech Corp Description and Business Overview
 Table 97. Genscript Biotech Corp Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Genscript Biotech Corp Neuroscience Antibody Product
 Table 99. Genscript Biotech Corp Recent Developments/Updates
 Table 100. Merck KGaA Company Information
 Table 101. Merck KGaA Description and Business Overview
 Table 102. Merck KGaA Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merck KGaA Neuroscience Antibody Product
 Table 104. Merck KGaA Recent Developments/Updates
 Table 105. Rockland Immunochemicals Inc Company Information
 Table 106. Rockland Immunochemicals Inc Description and Business Overview
 Table 107. Rockland Immunochemicals Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Rockland Immunochemicals Inc Neuroscience Antibody Product
 Table 109. Rockland Immunochemicals Inc Recent Developments/Updates
 Table 110. Santa Cruz Biotechnology Inc Company Information
 Table 111. Santa Cruz Biotechnology Inc Description and Business Overview
 Table 112. Santa Cruz Biotechnology Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Santa Cruz Biotechnology Inc Neuroscience Antibody Product
 Table 114. Santa Cruz Biotechnology Inc Recent Developments/Updates
 Table 115. Siemens Healthineers Company Information
 Table 116. Siemens Healthineers Description and Business Overview
 Table 117. Siemens Healthineers Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Siemens Healthineers Neuroscience Antibody Product
 Table 119. Siemens Healthineers Recent Developments/Updates
 Table 120. Tecan Group Ltd Company Information
 Table 121. Tecan Group Ltd Description and Business Overview
 Table 122. Tecan Group Ltd Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Tecan Group Ltd Neuroscience Antibody Product
 Table 124. Tecan Group Ltd Recent Developments/Updates
 Table 125. Thermo Fisher Scientific Inc Company Information
 Table 126. Thermo Fisher Scientific Inc Description and Business Overview
 Table 127. Thermo Fisher Scientific Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Thermo Fisher Scientific Inc Neuroscience Antibody Product
 Table 129. Thermo Fisher Scientific Inc Recent Developments/Updates
 Table 130. Enzo Life Sciences AG Company Information
 Table 131. Enzo Life Sciences AG Description and Business Overview
 Table 132. Enzo Life Sciences AG Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Enzo Life Sciences AG Neuroscience Antibody Product
 Table 134. Enzo Life Sciences AG Recent Developments/Updates
 Table 135. Neobioscience Company Information
 Table 136. Neobioscience Description and Business Overview
 Table 137. Neobioscience Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Neobioscience Neuroscience Antibody Product
 Table 139. Neobioscience Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Neuroscience Antibody Distributors List
 Table 143. Neuroscience Antibody Customers List
 Table 144. Neuroscience Antibody Market Trends
 Table 145. Neuroscience Antibody Market Drivers
 Table 146. Neuroscience Antibody Market Challenges
 Table 147. Neuroscience Antibody Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Neuroscience Antibody
 Figure 2. Global Neuroscience Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Neuroscience Antibody Market Share by Type: 2024 & 2031
 Figure 4. Antibodies Product Picture
 Figure 5. Research Reagents Product Picture
 Figure 6. Global Neuroscience Antibody Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Neuroscience Antibody Market Share by Application: 2024 & 2031
 Figure 8. Hospitals and Diagnostics Centers
 Figure 9. Academic and Research Institutes
 Figure 10. Pharmaceutical and Biotechnology Companies
 Figure 11. Global Neuroscience Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Neuroscience Antibody Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Neuroscience Antibody Sales (2020-2031) & (K Units)
 Figure 14. Global Neuroscience Antibody Average Price (US$/Unit) & (2020-2031)
 Figure 15. Neuroscience Antibody Report Years Considered
 Figure 16. Neuroscience Antibody Sales Share by Manufacturers in 2024
 Figure 17. Global Neuroscience Antibody Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Neuroscience Antibody Players: Market Share by Revenue in Neuroscience Antibody in 2024
 Figure 19. Neuroscience Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Neuroscience Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Neuroscience Antibody Sales Market Share by Country (2020-2031)
 Figure 22. North America Neuroscience Antibody Revenue Market Share by Country (2020-2031)
 Figure 23. United States Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Neuroscience Antibody Sales Market Share by Country (2020-2031)
 Figure 26. Europe Neuroscience Antibody Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Neuroscience Antibody Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Neuroscience Antibody Revenue Market Share by Region (2020-2031)
 Figure 34. China Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Neuroscience Antibody Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Neuroscience Antibody Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Neuroscience Antibody Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Neuroscience Antibody Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Neuroscience Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Neuroscience Antibody by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Neuroscience Antibody by Type (2020-2031)
 Figure 53. Global Neuroscience Antibody Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Neuroscience Antibody by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Neuroscience Antibody by Application (2020-2031)
 Figure 56. Global Neuroscience Antibody Price (US$/Unit) by Application (2020-2031)
 Figure 57. Neuroscience Antibody Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Neuroscience Antibodies and Assays Technology Market Research Report 2025
Neuroscience Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neuroscience Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Neuroscience Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurological Devices Market Research Report 2024
Neuroscience Medical Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Research Area Antibodies Market Research Report 2025
Global Nervous System Markers Market Research Report 2025
Global Central Nervous System Biomarkers Market Insights Forecast to 2030
Global Brain Biomarker Market Research Report 2024
Global Neurological Biomarkers for Alzheimer s and Parkinson s Diseases Market Research Report 2025
3D Neuroscience Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neural Biosensors Market Research Report 2025
Global Bcl 2 Antibody Market Research Report 2024
NeuN Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Synaptotagmin 1 Antibody Market Research Report 2024
RAB2 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
P53 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ubiquitin B Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DCT Antibody Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions